About the exhibition

Linkage between cell bioengineering technology and biological instrument industry exhibition

1. Perfect combination of upstream and downstream industrial chains in the field of biological fermentation industry, demonstrating innovation and new business opportunities in the era of biological industry economy;

2. Focus on presenting the industrial landscape, connecting government, industry, school, research and all sectors, and build a large service platform for the whole industrial chain of biotechnology from gene cell research, new drug research and development, products, technical services, raw materials, terminal applications, investment and financing;

Market background

Biomedical industry is one of the strategic emerging industries that China focuses on developing. At present, China is the second largest pharmaceutical market in the world after the United States, and is in an important stage of strategic transformation from "generic" to "innovative drugs". Precision medicine promotes the revolution of drug research and development. Gene technology and cell engineering have brought revolutionary changes to disease treatment. Medical devices have begun to become intelligent and standardized, providing new diagnostic and therapeutic means. Emerging biomedical service formats such as contract research and development (CRO), contract production (CMO), third-party testing, and health management have continued to rise and grow, and the biomedical industry has shown a rapid growth trend.

In recent years, the state and local governments have successively issued a series of policies to promote the construction of bioeconomy. Among them, Beijing, Tianjin, Hebei and Shandong are the leaders of Bohai Rim, Shanghai is the core of the Yangtze River Delta, Jiangsu and Zhejiang are the two wings, and Guangzhou and Shenzhen are the leaders of the Pearl River Delta. The three major regional biomedical key regions have gathered significantly, and Shanghai has gained development advantages in industrial competition.

This exhibition focuses on bioengineering, including five major projects, namely genetic engineering (genetic engineering), cell engineering, microbial engineering (fermentation engineering), enzyme engineering (biochemical engineering), bioreactor engineering and other new products, new technologies and new equipment in the industry. It will provide a one-stop service platform for industry discussion, technical exchange, networking, brand promotion and customer service, and hold more than 30 supporting conferences and activities in various forms at the same time, involving academic seminars, business matchmaking meetings, technical forums, trade fairs, special technical exchanges, scientific research achievements fairs, new product conferences, awards, etc., to create a highly international social biological industry ecosystem;

Exhibition introduction

Modern biotechnology is one of the most potential and dynamic science and technology fields in the contemporary era. In recent years, biotechnology, represented by genetic engineering, cell engineering, protein engineering, has developed rapidly, bringing hope to cure many intractable diseases: stem cell therapy and immune cell therapy have shown great application potential in the treatment of malignant tumors, inflammation, autoimmune diseases, metabolic diseases and other fields; With the development of single cell sequencing technology, single cell multiomics technology has emerged as the times require, and has become another sharp tool for studying tumors, autoimmune diseases, infectious diseases and complex diseases; Organ like technology has broad application prospects in disease modeling, drug discovery, drug screening, drug sensitivity detection and regenerative medicine; In recent years, the research and development of antibody drugs has been growing rapidly, including "classical antibodies", antibody coupled drugs (ADC), nano antibodies, double/multi specific antibodies and other forms of antibodies are increasing, and research and application in cancer, blood diseases, autoimmune diseases and other fields.

This exhibition invited many experts and scholars from various colleges and universities across the country to publish and discuss the hot topics of cell biology, providing the exhibitors and visitors with the most cutting-edge industry information, as well as showing the new technologies and products of the cell biology industry, which is very rich in content.

The mature "exhibition+conference" model of the Cell Biology Industry Conference has been highly praised by the guests, enterprises and representatives. Both in terms of exhibition scale, depth and breadth, and in terms of conference scale, quality and scope, it has been greatly improved, leading the industry. We continue to expand and improve the platform for cooperation and exchange of the whole industrial chain of cell biology.

Cell storage and treatment, tumor immunotherapy, stem cell therapy, anti-aging, CAR-T, solid tumor regenerative medicine, oncolytic virus, adeno-associated virus (AAV), lentivirus, adenovirus, cell therapy product registration and application, 3D cell culture, organ like culture, biological 3D printer, 3D cell imaging, innovative drug research and development, PD-1/L1 drug, early screening and early diagnosis, tumor metastasis and recurrence monitoring, molecular targeted treatment of tumors Targeted drug use, single cell sequencing, genome science and technology led by NGS technology, digital PCR, mass spectrometry, PCR derivative technology, precision medical industrialization process, molecular diagnosis, gene therapy, gene sequencing, nucleic acid detection, liquid biopsy and early screening of tumors, whole tumor cycle, tumor clinical treatment, genomics, biomarkers, translational medicine, biological products, culture media, reagents, instruments, consumables, clinical CRO CMO, CSO, biopharmaceutical CDMO, bioinformatics big data, AI assisted diagnosis, in vitro diagnosis, antibody, MALBAC technology, Crispr/Cas9 and gene editing technology, laboratory management and control, clinical application and research, tumor drug gene detection, policy supervision, organizational big data, industry clustering, industry status analysis and outlook.

Please contact the exhibition organizer for confirmation before participating in the exhibition.

• Company:Shanghai Ruimeng Exhibition Service Co., Ltd
• Truename:Mr.Chen
• Mobile:17612137926
• Address:Er Huan Xi Lu, Huaiyin District, Jinan City, Shandong Province

The information on this site comes from the network and related members, and the website has done its duty to review it. Due to the uncontrollability of the process of organizing the exhibition, some of the exhibition information in the station may change the subject matter, Extending or cancelling the event, please exhibitors and visitors must check with each other again before exhibiting! All the exhibitions in this site are not hosted/co-organized or organized, if there are any disputes during the exhibition, please hold the main responsibility of the exhibition organization! QQ Email: 523138820@qq.com WeChat: 523138820 Mobile: 15313206870